(Date:11/24/2009).../PRNewswire/--HealthRoboticstodayannounced,thatith...ed,investors.ThisrecentlyformedToronto-basedcompan...andwillmarket,install,andsupport,HealthRobotics,i....onaryproductofferingsi.v.STATION(TM),i.v.SOFT(TM),...eassistanceonan"asneeded,basis"toitsstrategicpartn...
(Date:11/24/2009)...ire-FirstCall/--CellTherapeutics,Inc.(CTI)(Nasdaqa...erJaffrayHealthCareConference.Theconferencewillbeh... CTIwillpresentonTuesday,December1at11:00a.m.Easte...presentationwillbeavailableat www.celltherapeutics... , ,PiperJaffrayHealthCareConference,NewYorkPalac...
(Date:11/23/2009)...ltra-fast communication, computation and more powe...ying to use quantum states as carriers of informat...sicists have shown, mathematically, how to gently ... while keeping the information intact. Their work ...ew Letters and highlighted with a Viewpoint in P...
(Date:11/23/2009)...PRNewswire-FirstCall/-YMBioSciencesInc.(NYSEAmex: ...ythatidentifiesandadvancesadiverseportfolioofpromi...ment,todayreportedthatCytopia(ASX:CYT)hascommenced...t,orally-administeredJAK1/JAK2inhibitor.Thetrialis...roposaltomergeCytopiaintoYMhasbeenpreviouslyannoun...
Breaking Biology Technology:Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 3YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 4 Other News:EMBARGO NOTE FOR REPORTERS: EACH PAPER LISTED IN THIS TIPSHEET IS...EMBARGOED FOR RELEASE UNTIL ITS DATE AND TIME OF PRESENTATION.......ANAHEIM, Calif. From stain-free clothing to scratch-resistant e
...eam of 16 experts from around the world report on ...s most endangered group of animals nonmarine moll...). The World Conservation Union lists in the IUCN ...reatened nonmarine mollusks, which is nearly half ...
...ey all have one thing in common: high-blood pressu...nearly 50 million people in USA, and over 1 billio...ily on world health, its underlying cause for the ...wn components involved in regulating blood pressur...
...eizures as well as after brief or repetitive epile...oss of neurons in the hippocampus after seizures m...ers of the Bcl-2 family are known to activate a pa...ncluding the 'executioner,' caspase-3. David Hens...
Nanotechnology highlights from the ACS national meeting in Anaheim, Calif., March 28-April 1 2Nanotechnology highlights from the ACS national meeting in Anaheim, Calif., March 28-April 1 3Nanotechnology highlights from the ACS national meeting in Anaheim, Calif., March 28-April 1 4Nanotechnology highlights from the ACS national meeting in Anaheim, Calif., March 28-April 1 5Report in BioScience details global decline of nonmarine mollusks 2WASHINGTON, DC, April 30 Increasing intake of antioxidant-rich cherries may help lower the risk of metabolic syndrome and cardiovascular disease, suggests a new study(1) presented today at the Exper
...in cities. The air we breathe and the water we dri.... As the human population expands, and cities beco... play a critical role in creating urban centers th...verlap. ... From May 1st to May 3rd, the Institute...
...ox outbreak in the United States, how long would i...udye to start protecting Americans by stimulating ...y Saint Louis University School of Medicine will a... vaccinations for smallpox were stopped in the Uni...
...imate Research Center, Emory University, have foun...heir hands, feet and limbs more flexibly than they...supporting the evolution of human language began w...language suggests. This study appears in the curre...
Cherries may help reduce metabolic syndrome and heart disease risk factors 2The Institute of Ecosystem Studies to host an international conference on ecology and urban design 2Smallpox outbreak: How long would it take for vaccines to protect people? Would it work? 2Ape gestures offer clues to the evolution of human communication 2